SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022

SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 A total of 36 studies in 10 Hot Line sessions were presented at this year ’s European Society of Cardiology Congress. What was notable in this 2022 edition compared to prior meetings was the increased number of investigator-initiated trials, of which I have selected three important ones for a brief discussion given their novel findings and potential impact on clinical p ractice. I will begin with the Secondary P...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research